SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-031813
Filing Date
2024-03-14
Accepted
2024-03-14 20:30:06
Documents
2
Period of Report
2024-03-09

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1540
2 EX-24.1 atos-ex24_1.htm EX-24.1 9336
  Complete submission text file 0000950170-24-031813.txt   12376
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104
Business Address
Cigler Tessa (Reporting) CIK: 0002015142 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35610 | Film No.: 24752164